2019 Annual Meeting: Data Generation (and Review Considerations) for Use of a Companion Diagnostic for a Group of Oncology Therapeutic Products | November 13, 2019 Share
2019 Annual Meeting: Immuno-Oncology Combination Drug Development for Patients with Disease Progression After Initial anti-PD-(L)1 Therapy | November 13, 2019 Share
Friends 2019 Annual Meeting Panel 1 – Characterizing the Use of External Controls for Augmenting Randomized Control Arms and Confirming Benefit | November 13, 2019 Share
2019 Annual Meeting: Characterizing the Use of External Controls for Augmenting Randomized Control Arms and Confirming Benefit | November 8, 2019 Share
8th Annual Blueprint for Breakthrough – Validating Real-World Endpoints for an Evolving Regulatory Landscape | September 18, 2019 Share
Opportunities for Combination Drug Development: Data Sources and Innovative Strategies to Assess Contribution of Components | July 17, 2019 Share
Friends Annual Meeting 2018 – Panel 3 Whitepaper: Real-Time Oncology Review and the Assessment Aid: Increasing Review Efficiency Through Standardization and Earlier Data Access | November 16, 2018 Share
